Basis of aggravated hepatic lipid metabolism by chronic stress in high-fat diet-fed rat

Endocrine

Volumn 48, Issue 2, 2015, Pages 483-492

  Han, Ying ^a   Lin, Min ^a   Wang, Xiaobin ^b   Guo, Keke ^a   Wang, Shanshan ^a   Sun, Mengfei ^a   Wang, Jiao ^a   Han, Xiaoyu ^a   Fu, Ting ^a   Hu, Yang ^a   Fu, Jihua ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Aggravation; Chronic stress; High fat diet (HFD); Lipid metabolic pathway; Very low density lipoprotein (VLDL) assembly

Indexed keywords

VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; LIPID DIET; LIVER; MALE; MENTAL STRESS; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CHOLESTEROL, VLDL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; LIVER; MALE; METABOLIC NETWORKS AND PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL;

EID: 84939872569     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0307-x     Document Type: Article

References (35)

1. J.A. Marrero, R.J. Fontana, G.L. Su et al., NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36(6), 1349–1354 (2002)
2. G. Marchesini, M. Brizi, A.M. Morselli-Labate et al., Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450–455 (1999)
3. M.M. Yeh, E.M. Brunt, Pathology of nonalcoholic fatty liver disease. Am. J. Clin. Pathol. 128, 837–847 (2007)
4. B. Czech, K. Weigand, I. Neumann et al., Combination of psychosocial stress and a NASH-inducing diet in mice. Z. Gastroenterol. (2013). doi:10.1055/s-0032-1331912
5. B.M. Tannenbaum, D.N. Brindley, G.S. Tannenbaum et al., High-fat feeding alters both basal and stress-induced hypothalamic– pituitary–adrenal activity in the rat. Am. J. Physiol. 273(6 Pt 1), E1168–E1177 (1997)
6. J.H. Fu, S.R. Xie, S.J. Kong et al., The combination of a high-fat diet and chronic stress aggravates insulin resistance in Wistar male rats. Exp. Clin. Endocrinol. Diabetes 117(7), 354–360 (2009)
7. G. Musso, R. Gambino, M. Cassader, Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48(1), 1–26 (2009)
8. P. Nguyen, V. Leray, M. Diez et al., Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) 92(3), 272–283 (2008)
9. D.P. Macfarlane, S. Forbes, B.R. Walker, Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. J. Endocrinol. 197, 189–204 (2008)
10. J.H. Fu, H.S. Sun, Y. Wang et al., The effects of a fat- and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male Wistar rats. Dig. Dis. Sci. 55(8), 2227–2236 (2010)
11. S. Gao, X. Han, J. Fu et al., Influence of chronic stress on the compositions of hepatic cholesterol and triglyceride in male Wistar rats fed a high fat diet. Hepatol. Res. 42(7), 686–695 (2012)
12. S.M. Haffner, E. Kennedy, C. Gonzalez et al., A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19, 1138–1141 (1996)
13. D.E. Kleiner, E.M. Brunt, M. Van Natta et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6), 1313–1321 (2005)
14. R.S. Kukreja, B.N. Datta, R.N. Chakravarti, Catecholamine-induced aggravation of aortic and coronary atherosclerosis in monkeys. Atherosclerosis 40, 291–298 (1981)
15. E. Kitrakia, G. Soulisa, K. Gerozissisb, Impaired neuroendocrine response to stress following a short-term fat-enriched diet. Neuroendocrinology 79, 338–345 (2004)
16. A. Legendre, B.S. Ruth, Exaggerated response to mild stress in rats fed high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, 1288–1294 (2006)
17. R. Collu, Y. Taché, J.R. Ducharme, Hormonal modifications induced by chronic stress in rats. J. Steroid. Biochem. 11(1C), 989–1000 (1979)
18. L.A. Adams, A. Feldstein, K.D. Lindor et al., Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 39, 909–914 (2004)
19. D.K. Bloomfield, Dynamics of cholesterol metabolism. I. Factors regulating total sterol biosynthesis and accumulation in the rat. Proc. Natl. Acad. Sci. USA 50, 117–124 (1963)
20. F. Foufelle, P. Ferré, New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366(Pt 2), 377–391 (2002)
21. H.S. Sul, D. Wang, Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription. Annu. Rev. Nutr. 18, 331–351 (1998)
22. L.S. Sidossis, B. Mittendorfer, E. Walser et al., Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am. J. Physiol. 275(5 Pt 1), E798–E805 (1998)
23. B. Hubbard, H. Doege, S. Punreddy et al., Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity. Gastroenterology 130(4), 1259–1269 (2006)
24. M. Schreurs, F. Kuipers, F.R. van der Leij, Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes. Rev. 11(5), 380–388 (2010)
25. L. Yang, Y. Zhang, S. Wang et al., Decreased liver peroxisomal β-oxidation accompanied by changes in brain fatty acid composition in aged rats. Neurol Sci. 35(2), 289–293 (2014)
26. M. Zhou, E.A. Fisher, H.N. Ginsberg, Regulated co-translational ubiquitination of apoliprotein B100. A new paradigm for proteasomal degradation of a secretory protein. J. Biol. Chem. 273, 24649–24653 (1998)
27. R.A. Davis, Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim. Biophys. Acta 1440(1), 1–31 (1999)
28. E.A. Fisher, The degradation of apolipoprotein B100: Multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways. Biochim. Biophys. Acta 1821(5), 778–781 (2012)
29. C.C. Chang, N. Sakashita, K. Ornvold et al., Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 275(36), 28083–28092 (2000)
30. C. Leon, J.S. Hill, K.M. Wasan, Potential role of acyl-coenzyme A: cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs. Pharm. Res. 22(10), 1578–1588 (2005)
31. L.J. Wilcox, N.M. Borradaile, L.E. de Dreu et al., Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTTP. J. Lipid Res. 42(5), 725–734 (2001)
32. E.A. Fisher, M. Pan, X. Chen et al., The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 276, 27855–27863 (2001)
33. B. Fromenty, Fat accretion in a subpopulation of hepatocytes as a strategy to protect the whole liver against oxidative stress and lipotoxicity. Clin. Res. Hepatol. Gastroenterol. 37(6), 553–555 (2013)
34. C.N. Wang, R.S. McLeod, Z. Yao et al., Effects of dexamethasone on the synthesis, degradation, and secretion of apolipoprotein B in cultured rat hepatocytes. Arterioscler. Thromb. Vasc. Biol. 15(9), 1481–1491 (1995)
35. M. Devaki, R. Nirupama, H.N. Yajurvedi, Chronic stress-induced oxidative damage and hyperlipidemia are accompanied by atherosclerotic development in rats. Stress 16(2), 233–243 (2013)